CLBS-Caladrius Biosciences-NASDAQĬaladrius has three different products to treat autoimmune and cardiovascular diseases.
They develop and commercialize medicines for inflammatory disorders and cancer. Their technology uses umbilical cord cells. CCEL-Cryo-Cell International-OTCQBĬCEL is hoping to make advances in regenerative medicine with the cryo-preservation of stem cells. They’re also looking to treat osteoarthritis. They develop immunotherapies for cancer patients and also develop stem cell therapies for degenerative problems. They discover, develop, and commercialize first-class therapeutics in the biological field. They’re also looking into treating metabolic disorders. This company is developing stem cell treatments for disc degeneration in chronic back pain. It is focused on ground-breaking research in the field of nanotechnology and is pursuing exosomes and other micro vesicles as the next frontier in stem cell-based therapeutics.
Organicell is an integrated exosome therapeutics company. BPSR-Organicell Regenerative Medicine Inc-OTC BLUE-bluebird bio-NASDAQīluebird Bio develops gene therapies. BSEM-Biostem Technologies Inc-OTCīioStem Technologies develops amniotic membrane and umbilical cord tissue derived products for use in regenerative medicine, including: RHEO™, OROPRO™, VENDAJE™ and VENDAJE™ OPTIC. such as MS, Huntington’s Disease, and Parkinson’s among others. They have a wide array of products looking to fight ALS and other neurodegenerative diseases. BCDA-Biocardia-NASDAQīiocardia is a company that is involved with medicine for cardiovascular issues. ATHX-Athersys-NASDAQĪrthersys is hoping to treat ischemic stroke, neurological disease, cardiovascular problems, and immune and inflammatory diseases. They also import, export, and develop pharmaceutical products. Till at the University of Toronto in the 1960s.Astellas is a biotech company dealing with cancer, specifically bladder cancer. Research into stem cells grew out of findings by Ernest A. Embryonic cell lines and autologous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation have also been proposed as promising candidates for future therapies. Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves.
By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.Īdult stem cells are frequently used in various medical therapies (e.g., bone marrow transplantation). Of all stem cell types, autologous harvesting involves the least risk. Stem cells can also be taken from umbilical cord blood just after birth. There are three known accessible sources of autologous adult stem cells in humans:īone marrow, adipose tissue, and blood. In a developing embryo, stem cells can differentiate into all the specialized cells-ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)-but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.
0 kommentar(er)
